This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The overall goal of developing a Molecular Biology Research Activity (MBRA) is to provide the university biomedical research investigators with contemporary molecular biology technology and technical expertise. This will strengthen the research infrastructure at Florida A&M University. The long-term goal of this effort is to establish beneficial resources that will result in increased molecular biology expertise of the research faculty, continual investigator collaborations, and foster new biomedical research collaborative ventures. Development of the MBRA will also increase new faculty recruitment opportunities at Florida A&M University To achieve these goals of this new RCMI activity, the following specific aims have been developed:
Specific Aim 1 :Establish the equipment infrastructure needed for molecular biology research. This will be accomplished through coordinated efforts of expansion by purchasing new needed molecular biology equipment and consolidation with molecular biology equipment already in place.
Specific Aim 2 : Develop a MBRA collaborative environment for biomedical research investigators. The MBRA personnel will consist of the activity leader, a research scientist level molecular biologist and a research associate molecular biologist Together they will form the hub for collaborative research with other biomedical research investigators.
Specific Aim 3 : Facilitate avenues by which faculty can receive molecular biology training. MBRA scientist will provide technical expertise in design and implementation of experiments, ongoing advice during performance of experiments, faculty mentoring and workshops. Development of the MBRA is one avenue by which the identified need for increased molecular biological approaches to address development, intervention and treatment of disease states. The expected outcomes will be a positive impact on biomedical research at Florida A&M University through collaborative sharing of technology resources and equipment and an increase in the number of investigators and scientifically meritorious productivity resulting in increased extramural funding and numbers of publications is also expected
Showing the most recent 10 out of 204 publications
